Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01218081
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
MMG | 4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin- 3-yl)benzoic acid | A | 3HDM | 0.7 | |
2SM | methyl 2-{[(4-methylpyrimidin-2- yl)carbamoyl]sulfamoyl}benzoate | A | 3EA4 | 0.71 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.71 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.71 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.73 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.73 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.71 | |
NHR | 2-{4-[2-(2-AMINO-4-HYDROXY-QUINAZOLIN- 6-YL)-1-CARBOXY-ETHYL]-BENZOYLAMINO}- PENTANEDIOIC ACID | A,B | 1C3E | 0.72 | |
35A | N-[(5R,14R)-5-AMINO-5,14-DIMETHYL- 4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA- 1(21),7(22),8,10,17,19-HEXAEN-19- YL]-N-METHYLMETHANESULFONAMIDE | A | 2PH8 | 0.74 | |
RAJ | N-{3-[3-(DIMETHYLAMINO)PROPYL]- 5-(TRIFLUOROMETHYL)PHENYL}-4-METHYL- 3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]BENZAMIDE | X | 2OO8 | 0.7 | |
RAJ | N-{3-[3-(DIMETHYLAMINO)PROPYL]- 5-(TRIFLUOROMETHYL)PHENYL}-4-METHYL- 3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]BENZAMIDE | A | 3BE2 | 0.7 | |
P40 | N-cyclopropyl-4-methyl-3-{2-[(2- morpholin-4-ylethyl)amino]quinazolin- 6-yl}benzamide | A | 3DT1 | 0.71 | |
1SM | METHYL 2-[({[(4,6-DIMETHYLPYRIMIDIN- 2-YL)AMINO]CARBONYL}AMINO)SULFONYL]BENZOATE | A,B | 1T9C | 0.72 | |
1SM | METHYL 2-[({[(4,6-DIMETHYLPYRIMIDIN- 2-YL)AMINO]CARBONYL}AMINO)SULFONYL]BENZOATE | A | 1YI0 | 0.72 | |
CY0 | S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]- 3-OXOPROPYL}-L-CYSTEINE | A | 2J5E | 0.7 | |
NIX | NALIDIXIC ACID | A,B | 2BQ2 | 0.7 | |
TQ6 | 5-(4-MORPHOLIN-4-YL-PHENYLSULFANYL)- 2,4-QUINAZOLINEDIAMINE | A,B | 1IA4 | 0.72 | |
24X | H,L | 2EC9 | 0.72 | ||
P16 | 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}- 8-METHYLPYRIDO[2,3-D]PYRIMIDIN- 7(8H)-ONE | A | 2FO0 | 0.7 | |
P16 | 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}- 8-METHYLPYRIDO[2,3-D]PYRIMIDIN- 7(8H)-ONE | A | 1OPK | 0.7 | |
P16 | 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}- 8-METHYLPYRIDO[2,3-D]PYRIMIDIN- 7(8H)-ONE | A,B | 1OPL | 0.7 | |
P16 | 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}- 8-METHYLPYRIDO[2,3-D]PYRIMIDIN- 7(8H)-ONE | A,B | 2G2H | 0.7 |